(Rac)-Minzasolmin, CAS [[1802518-63-3]]

Produktübersicht

• Artikelname: (Rac)-Minzasolmin, CAS [[1802518-63-3]]
• Artikelnummer: MCE-HY-125287
• Hersteller Artikelnummer: HY-125287
• Alternativnummer: MCE-HY-125287-5MG,MCE-HY-125287-25MG,MCE-HY-125287-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: (Rac)-UCB0599, NPT200-11

Produktbeschreibung

(Rac)-Minzasolmin ((Rac)-UCB0599, NPT200-11) is a blood-brain barrier penetrated alpha-synuclein (ASYN) misfolding inhibitor. (Rac)-Minzasolmin acts on the early stage of ASYN aggregation process, by replacing the membrane-bound oligomers ASYN, allowing them to revert to the monomeric form, while preventing pathological aggregation. (Rac)-Minzasolmin effectively improves the ASYN deposition in the retina and the neuro-pathological indicators in two alpha-synuclein transgenic mouse models. (Rac)-Minzasolmin can be used for the studies of Parkinsons disease (PD) and dementia with Lewy bodies (DLB)[1].

Produkteigenschaften

• Molekulargewicht: 425.59
• Reinheit: 99.87
• CAS Nummer: [1802518-63-3]
• Formel: C23H31N5OS
• Target-Kategorie: alpha-synuclein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound